Democrats prepare for health care overhaul
This "tabula rasa" philosophy suggests that because the previous consensus on health policy has been...
This "tabula rasa" philosophy suggests that because the previous consensus on health policy has been...
In a landmark revelation for the metabolic health landscape, Eli Lilly and Company announced late-stage...
The Food and Drug Administration official in charge of reviewing infectious disease products is leaving...
The landscape of modern oncology was fundamentally shifted with the advent of CAR-T cell therapy,...
The approval of Icotyde comes at a pivotal time for the global pharmaceutical industry, particularly...
The firm’s founders—Zavain Dar, Nan Li, and Adam Goulburn—represent a new guard of venture capitalists...
Twenty years ago, during a walkthrough and shadowing session at a Federally Qualified Health Center...
In the study led by researchers from the Mass General Brigham Neuroscience Institute and Brown...
The weight loss figure reported by Structure Therapeutics is particularly striking when placed alongside the...
As the second term of the Trump administration moves into its second year, a striking...